Turkish Version of Multidimensional Outcome Expectations For Exercise Scale (MOEES

January 17, 2023 updated by: Yusuf Ziya Aarslan

Investigation of the Validity and Reliability of the Turkish Version of Multidimensional Outcome Expectations For Exercise Scale (MOEES)

The Multidimensional Outcome Expectations For Exercise Scale (MOEES) was developed to assess the multidimensional outcome expectations of exercise. The Turkish validity and reliability study of the scale, originally in English, has not been conducted before. The aim of this study is to develop the Turkish version of the Multidimensional Outcome Expectations For Exercise Scale (MOEES), and to report its reliability assessment.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The Turkish version of The Multidimensional Outcome Expectations For Exercise Scale (MOEES) will be asked face to face with patients diagnosed with cardiac disease.

Study Type

Observational

Enrollment (Anticipated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Yusuf Ziya Arslan, MSc.
  • Phone Number: +90531221 26 00
  • Email: arsbng@gmail.com

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients diagnosed with cardiac disease.

Description

Inclusion Criteria:

  • ≥ 18 years.
  • Be diagnosed with heart disease.
  • Having at least one of the cardiac risk factors (hypertension, diabetes mellitus, hyperlipidemia/dyslipidemia, overweight or obesity (BMI>25), physical inactivity (less than 150 minutes of moderate-intensity exercise per week).
  • To agree to participate in the study.
  • Being able to write and speak in Turkish.

Exclusion Criteria:

  • < 18 years.
  • Lack of cooperation.
  • No heart disease.
  • Mental retardation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
patients diagnosed with cardiac disease
Other: validity and reability study
Validity and reliability assessment of the Turkish version of the Multidimensional Outcome Expectations For Exercise Scale (MOEES).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reliability and Validity of MOEES by Correlation Analysis.
Time Frame: 6 months
with MOEES will be researched
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tampa Scale of Kinesiophobia for Heart
Time Frame: 6 months
The kinesiophobia levels of the patients will be evaluated.
6 months
International Physical Activity Questionnaire
Time Frame: 6 months
The physical activity levels of the patients will be evaluated.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Yusuf Ziya Aarslan

Collaborators

Irem Hüzmeli

Investigators

  • Principal Investigator: Yusuf Ziya Arslan, MSc., Mustafa Kemal University
  • Study Director: İrem Hüzmeli, Dr., Mustafa Kemal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 6, 2023

Primary Completion (Anticipated)

May 6, 2023

Study Completion (Anticipated)

June 6, 2023

Study Registration Dates

First Submitted

January 17, 2023

First Submitted That Met QC Criteria

January 17, 2023

First Posted (Estimate)

January 26, 2023

Study Record Updates

Last Update Posted (Estimate)

January 26, 2023

Last Update Submitted That Met QC Criteria

January 17, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • MKU-YZA-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Care Acceptor Health Knowledge, Attitudes, Practice Patient Participation

Clinical Trials on validity and reability study

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe